Melanoma

May 10, 2016May 10, 2016

New Compound Successfully Targets Mutation Linked to Melanoma and Lymphoma

Melanoma, News

A study has shown that a new compound, JQEZ5, may help to treat certain types of cancers, particularly lymphoma and melanoma. The article, published in the journal Nature Medicine, is titled “An oncogenic Ezh2 mutation induces ... Read more

May 5, 2016May 5, 2016

Gene Expression Test of Metastasis Risk in Melanoma Patients Validated in Independent Study

Melanoma, News

An independent study of Castle Biosciences’ DecisionDx-Melanoma gene expression profile test, used to identify the risk of metastasis in patients with stage 1 or 2 cutaneous melanoma, verified the accuracy ... Read more

May 22, 2015May 22, 2015

Researchers Discover a Melanoma-Intrinsic Pathway That Blocks Anti-Tumor Immunity

Melanoma, News

Researchers at The University of Chicago recently published in the journal Nature the discovery of a melanoma-cell-intrinsic oncogenic pathway that can mediate cancer immune evasion by inhibiting T cells (the primary ... Read more

May 20, 2015May 20, 2015

Genentech to Present Melanoma Therapy at ASCO Meeting

Melanoma, News

Genentech, a biopharmaceutical firm that is part of the Roche Group, will present over 275 abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting, which is taking place between May 29th ... Read more

May 15, 2015May 15, 2015

Provectus’ Synthesis Patent Granted by Europe and Japan

Melanoma, News

Clinical-stage dermatology company Provectus Biopharmaceuticals, which works in the fields of oncology and dermatology, has been granted allowance of its patent application from both the European Patent Office and the Japanese ... Read more

May 13, 2015May 13, 2015

DNA Repair Mapped by UNC Researchers

Melanoma, News

Groundbreaking work in mapping damaged DNA repair in the human genome reached a milestone at the University of North Carolina School of Medicine and Lineberger Comprehensive Cancer Center. The new ... Read more

May 11, 2015May 11, 2015

Cryoport Supports NeoStem’s Intus Study For Metastatic Melanoma Treatment

Melanoma, News

New York based biopharmaceutical company, NeoStem, is developing an autologous immunotherapy using patients’ own tumor cells to maximize individuals’ immune system’s ability to identify and eliminate cancer-initiating cells that NeoStem ... Read more

May 6, 2015May 8, 2015

May is National Melanoma Skin Cancer Prevention Month

Melanoma, News

The month of May has been established by the American Academy of Dermatology as National Melanoma Skin Cancer Prevention Month with the goal of raising awareness of melanoma skin cancer and ... Read more

May 4, 2015May 4, 2015

Amgen Presents Details Of Biologics License Application For Metastatic Melanoma Drug Talimogene Laherparepvec To Joint FDA Advisory Committee

Melanoma, News

A Joint Meeting of the U.S. Food and Drug Administration’s (FDA) Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) and Oncologic Drugs Advisory Committee (ODAC) on Wednesday, April 29, 2015 ... Read more

April 30, 2015April 30, 2015

BioNTech Collaborative Study Reveals a Potential New Strategy for Personalized Melanoma, Cancer Immunotherapy

Melanoma, News

Biotechnology company BioNTech AG recently announced the publication of a study entitled “Mutant MHC class II epitopes drive therapeutic immune responses to cancer” in the internationally renowned journal Nature. The ... Read more

April 29, 2015April 29, 2015

β-catenin Protein Activators Found to be Effective Against Melanoma Cells

Melanoma, News

A variety of therapeutic options for melanoma have been developed since 2011, changing the way advanced melanomas are treated. Some treatments focus on specific mutations found in melanoma patients, such as ... Read more

April 27, 2015April 27, 2015

Common Skin Mole Mutations Related To Hundreds Of Cancer Possibilities

Melanoma, News

An international team of scientists led by Houston Methodist researchers managed to identify in mice models hundreds of possible new genes that might transform benign skin growths into deadly melanomas. These results have been ... Read more

April 24, 2015April 24, 2015

Provectus and Pfizer Receive Patent Allowance for Experimental Therapy in Combination with Systemic Immunotherapy For Melanoma Treatment

Melanoma, News

Provectus Biopharmaceuticals, Inc. a company specialized in developing oncology and dermatology therapies, recently announced that is has received from the US Patent and Trademark Office a Notice of Allowance for ... Read more

April 23, 2015April 23, 2015

New Immunotherapy Reduces Tumors in Metastatic Melanoma Patients

Melanoma, News

Scientists at Penn Abramson Cancer Center recently presented groundbreaking results showing how combining an immune-checkpoint inhibitor – tremelimumab – with an anti-CD40 monoclonal antibody drug induces a safe and effective response ... Read more

April 21, 2015April 21, 2015

Stanford Researchers Discover a Cell Type Linked to Scar Formation, Fibrosis and Melanoma Growth

Melanoma, News

Researchers at Stanford University School of Medicine recently published in the journal Science the discovery of a specific skin cell type that is associated to wound healing by scarring, radiation-induced fibrosis ... Read more

April 20, 2015April 20, 2015

Study Shows Advertising Influences Tanning Behavior

Melanoma, News

Advertising and magazines that present tanning on a beach as a paradise in exotic vacation destinations with smiling, tanned models may be influencing people to search out ways of getting more tanned, ... Read more

April 17, 2015April 18, 2015

Researchers Discover a Protein That Can Improve Malignant Melanoma Diagnosis and Possibly Treatment

Melanoma, News

Researchers at the University of Aarhus and the Aarhus University Hospital in Denmark discovered a specific protein associated with malignant melanomas that could be used as a marker for earlier diagnosis and potentially ... Read more

April 16, 2015April 16, 2015

Study Reports Fewer New Cases of Pediatric Melanoma

Melanoma, News

Findings from a new study published in The Journal of Pediatrics revealed that the rate of new pediatric melanoma cases decreased between 2004 and 2010 in the United States. A research team from ... Read more

April 13, 2015April 14, 2015

Melanoma Metastatic Potential is Fuelled by CXCR3 Signaling

Melanoma, News

In a new study entitled “CXCR3 signaling in BRAFWT melanoma increases IL-8 expression and tumorigenicity,” researchers revealed that CXCR3 signaling promotes wild-type BRAF melanoma progression by inducing invasive and metastatic characteristics. The ... Read more

April 10, 2015April 10, 2015

Researchers Conduct First Systematic Study to Evaluate Anti-Cancer Nanoparticles Safety

Melanoma, News

An international multidisciplinary team published a study in the journal Nano Research establishing the safety of specific nanoparticles for cancer therapies using human skin cells. The study is entitled “Cytotoxicity ... Read more